FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

734 letters match. Newest first.

  1. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  2. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk
  3. Fagron Compounding Services, LLC dba Fagron Sterile Service

    FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.

    High risk
  4. Chara Biologics, Inc.

    FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.

    High risk
  5. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  6. Evolutionary Biologics Inc.

    FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.

    High risk
  7. www.weightcrunchshop.com

    FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.

    High risk
  8. INCELL Corporation LLC

    FDA warned INCELL Corporation for making an unapproved amniotic-fluid drug without validating its sterile manufacturing process.

    High risk
  9. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  10. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  11. Evolution Pets LLC

    Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.

    High risk
  12. Energetic Essences, LLC dba Pet Essences

    FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.

    High risk
  13. Intermarket Industries Inc. dba Doc Ackerman Pet Products

    FDA warns Doc Ackerman Pet Products that its Epilepsy & Seizure Formula for dogs and cats is an unapproved new animal drug.

    High risk
  14. Prime Vitality, Inc. dba Prime Peptides

    FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.

    High risk
  15. Swisschems

    Swisschems sells Semaglutide and Retatrutide as unapproved new drugs despite research-chemical labeling.

    High risk
  16. Summit Research Peptides

    FDA warned Summit Research Peptides for selling unapproved semaglutide, retatrutide, cagrilintide, tirzepatide, and mazdutide with drug claims.

    High risk
  17. Veronvy

    FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."

    Medium
  18. Mena Food Group, LLC

    FDA says Mena Food Group made ready-to-eat bakery products under insanitary conditions and without allergen or CGMP controls.

    High risk
  19. Stew Leonard’s Holdings LLC

    Stew Leonard's Danbury, CT bakery cookies were misbranded: labels omitted peanut and egg allergens tied to a consumer death.

    High risk
  20. Centura Pharmaceuticals Inc

    FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.

    High risk
  21. Grupo VPAS C.A.

    FDA warns Venezuela seafood processor Grupo VPAS over inadequate seafood safety plan controls for histamine and ciguatera in frozen Medregal fillets.

    High risk
  22. Maruhachi Muramatsu Inc., Danchi Factory

    FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

    High risk
  23. Kyokuyo Global Seafoods Co. LTD.

    FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.

    High risk
  24. Procesadora Vikingo C.A.

    FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.

    High risk
  25. Graceleigh, Inc. dba Sammy’s Milk

    Food Labeling/Misbranded

  26. LEEL Tech

    FDA warns LEEL Tech that its CLYN, LEEL, and SOLID CPAP cleaners/sanitizers are sold in the U.S. without required clearance or approval.

    Medium
  27. Adventure Innovations LLC

    FDA says Adventure Innovations sold Sani Bot D3, a CPAP cleaner, without device clearance or approval.

    Medium
  28. Natures Pillows, Inc. and Top Dog Direct, LLC

    FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.

    High risk
  29. AnuMed International, LLC

    FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.

    High risk
  30. Media Networks Sydney Pty Limited

    Media Networks Sydney failed to properly list Mylanta 2go Antacid and Microlax Enema with FDA, making them misbranded.

    Low
  31. Manabi Export Panama S.A.

    FDA cited Panama seafood processor Manabi Export for missing HACCP (food-safety plan) controls on ready-to-eat cooked clam meat in reduced-oxygen packaging.

    High risk
  32. LS Promotions Inc.

    LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.

    High risk
  33. BullyKamp Products LLC

    BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.

    High risk
  34. Top Dog Pet Store LLC dba The Bulldog Cartel

    Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.

    High risk
  35. Txsyn Int. LLC

    FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.

    Medium
  36. Baylab USA, LLC

    Baylab USA sold unapproved Level 1 masks, KN95 respirators and unclear colors and kids' versions of its Level 3 mask, FDA says.

    High risk
  37. Walmart, Inc.

    FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.

    High risk
  38. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  39. White Label Leaf, LLC/Flying Monkey US, LLC

    FDA warned Flying Monkey US that its Delta-8 THC gummies are adulterated food and are being sold as unapproved new drugs.

    High risk
  40. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  41. West Coast Laboratories, Inc.

    FDA warned West Coast Laboratories over dietary supplements made without required manufacturing controls and illegally labeled.

    High risk
  42. Jiangsu Shenli Medical Production Co., Ltd.

    FDA: Chinese syringe maker Jiangsu Shenli lacked design controls and device master records, halting US imports.

    High risk
  43. Shamrockshrooms.com

    Shamrockshrooms.com sells Delta-8 THC gummy candies that FDA calls adulterated and FTC says imitate children's candy.

    High risk
  44. Donggang Wanrui Food Co., Ltd.

    Donggang Wanrui Food Co., Ltd. lacked required seafood safety plan monitoring and records for raw frozen octopus and crab.

    High risk
  45. ARG Laboratories, Inc.

    FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.

    High risk
  46. AG Essence, Inc.

    FDA warned AG Essence that its Banda-SiL silver wound gels are adulterated and misbranded because they are sold without required FDA marketing clearance.

    High risk
  47. Premier Manufacturing Products, LLC

    FDA warns Premier Manufacturing over Tianaa tianeptine products sold as unapproved new drugs.

    High risk
  48. Ozempen.com

    FDA warned Ozempen.com it sells unapproved, misbranded semaglutide pens to U.S. consumers online.

    High risk
  49. Bimbo Bakeries USA, Inc.

    FDA says Bimbo Bakeries USA misbranded Sara Lee and Brownberry bread labels, listing sesame and tree nuts not in the products.

    Medium
  50. Aqualex Co., Ltd.

    Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.

    High risk